THE FDA AUTHORIZED A PILL TO TREAT COVID. HERE’S WHAT WE KNOW ABOUT IT

Written by on January 3, 2022


THE FDA AUTHORIZED A PILL TO TREAT COVID. HERE'S WHAT WE KNOW ABOUT IT

Shared By Peter Boykin – American Political Commentator / Citizen Journalist

Pfizer is buying a biopharmaceutical company that works on cardiovascular and inflammatory medicines… It’s a curious purchase, considering that one of the most prevalent side-effects of Pfizer’s covid vaccine is heart inflammation.

Sounds like Pfizer is double-dipping on profits: Make money off the vaccine that causes heart inflammation. Then make more money off treatments for the inflammation you caused.
Gross.

Pfizer is Buying a Cardiovascular Biopharma Company for $6.7Bn.

THE FDA AUTHORIZED A PILL TO TREAT COVID. HERE’S WHAT WE KNOW ABOUT IT

 

The Food and Drug Administration (FDA) just approved the first pill to treat newly infected Covid patients, and it can be taken from the comfort of your own home. The pill has been proven to fight off the worst effects of the virus.

The pill is called Paxlovid and is created by Pfizer. The FDA authorization allows doctors to prescribe Paxlovid for high-risk patients, ages 12 and over. Clinical tries show it’s most effective if taken in the first five days that symptoms arise.

 https://rumble.com/vrvavi-the-fda-authorized-a-pill-to-treat-covid.-heres-what-we-know-about-it.html

It’s only going to high-risk patients right now because there is a limited supply: roughly 60,000 courses available in the U.S. But they anticipate having 250,000 available by the end of January.
The major benefit to taking this pill as opposed to some of the other therapeutic treatments that are currently available is that you don’t need to be in a clinical setting to take it and it doesn’t require an IV or injection. Paxlovid is just three pills taken twice a day for five days at home.

Clinical trials found that the pill cut hospitalizations and deaths by 89% when given to people with mild-to-moderate Covid within three days of symptoms arising.

It also found:
Less than 1% of patients were hospitalized and none died at the end of the 30-day trial
Compared to 6.5% of placebo group patients who were hospitalized, which included 9 deaths
This isn’t a new concoction: This new pill is part of a family of antiviral drugs that have been around for decades known as protease inhibitors which block a key enzyme that viruses need to multiply in the body. This type of anti-viral has been used to treat HIV and hepatitis C in the past.

Therapeutics > Vaccines: I have always favored the development of effective therapeutic over mass vaccination. President Trump felt the same way. After he beat Covid in October of 2020, he said:
“We have to get [theraputics] approved, and I want to get ‘em to the hospitals where people are feeling badly. That’s much more important to me than the vaccine.”
So this pill seems like a step in the right direction.

The flip side: With all of that said, Pfizer charges the U.S. government $500 per treatment. So the Pfizer medical machine is making money hand over fist between this and their mRNA jabs. So there are definitely questions to be raised over why this treatment is accepted, but cheap, widely available drugs like Ivermectin and Hydroxy aren’t. But that’s a whole other topic for another day…

[Source: Associated Press]

 

THE FDA AUTHORIZED A PILL TO TREAT COVID. HERE’S WHAT WE KNOW ABOUT IT

THE FDA AUTHORIZED A PILL TO TREAT COVID. HERE’S WHAT WE KNOW ABOUT IT

Shared by

#GoRightNews https://GoRightNews.com


#GoRight with Peter R Boykin

#GoRightNews

Donate To Support GoRightNews

GoRightNews.com

GoRightNews's Twitter

Go Right News Facebook


#Boykin4Congress
Peter Boykin For United States Congress

Donate to Boykin For Congress

BoykinForCongress Twitter

BoykinForCongress.com

BoykinForCongress Telegram


Join Peter Boykin on Telegram

@RealPeterBoykin on Telegram


Join Peter Boykin on Facebook

Peter Boykin's Facebook


Join Peter Boykin on GAB

Peter Boykin's GAB


Support The Podcast and Website
To Donate to the Podcast (NOT THE CAMPAIGN)

Support The Podcast






Current track

Title

Artist

Background